NCT07568964Not yet recruiting
Evaluation of Probiotics' Effect on Atrial Fibrillation Recurrence in Patients Undergoing Cardioversion
Effect of Probiotics on Atrial Fibrillation Outcome in Patients Undergoing Cardioversion
Source: ClinicalTrials.gov · Last updated 6 May 2026
Brief summary (registry, in English)
The aim of this clinical study is to evaluate the efficacy and tolerability of probiotics on atrial fibrillation recurrence.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 56 (estimated)
- First submitted
- 10 Apr 2026
- Start date
- 10 May 2026
- Primary completion date
- 10 May 2027
- Lead sponsor
- Ain Shams University
- Diseases
- Atrial fibrillation
- NCT number
- NCT07568964
What you commit to
- Study type: Interventional
- Planned participants: 56
- From 10 May 2026 to the primary completion date, 10 May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of probiotic supplementation in the previous 6 weeks
- Ongoing treatment with immunosuppressive therapies
Other illness
- Autoimmune diseases
- Active Infection
- History of or known allergy or intolerability to the study medications
Other
- Pregnant or breast-feeding patients
- Active participation in another clinical study
Who the study is looking for
- Female or male aged 40 years or above with BMI less than 40
- Persistent AF patients directly after cardioversion
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ain Shams University's Hospital Coordinator of this site? Confirm its status | Cairo | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.